Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • libiyagirl
    Member
    • Jan 2011
    • 27

    #1

    driver identification using CHASM in cancer

    Hello,

    I am trying to run CHASM "BuildClassifier" command. But it always return error saying:

    Traceback (most recent call last):
    File "<string>", line 31, in <module>
    File "/home/andywong86/pyinstaller-1.4/iu.py", line 436, in importHook
    File "/home/andywong86/pyinstaller-1.4/iu.py", line 521, in doimport
    File "./build/pyi.linux2/BuildClassifier/outPYZ1.pyz/util.makemuts", line 23, in <module>
    File "./build/pyi.linux2/BuildClassifier/outPYZ1.pyz/util.genes", line 59, in __init__
    IOError: [Errno 2] No such file or directory: './ClassifierPack/refseq.info'

    I don't know what's happening. Anyone used CHASM before?

    Thank you very much!
  • nyk
    Junior Member
    • Sep 2011
    • 1

    #2
    I assume you have to set the CHASMDIR evironment variable, because I got a similar error when I did not do that, if I remember correctly.
    Because I'm going to use CHASM from a script, I add the setting of that variable before the BuildClassifier command. Like this:
    CHASMDIR=/opt/CHASM /opt/CHASM/BuildClassifier -m /opt/CHASM/ClassifierPack/contexts/BR.context -i /opt/CHASM/ClassifierPack/calibrate.tmps -o breast_cancer

    I also have a question:
    Is it the idea to use the "calibrate" set of mutations for building the classifier, like I did in the above command? And then use RunChasm on the mutation-list of cancer samples I want to test?
    Or should the model be calibrated on the *same* set of mutations I will use RunChasm on?
    Last edited by nyk; 09-28-2011, 02:08 PM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...